Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Dan'ge Fentong Capsules for diabetic peripheral neuropathy
CTR20243261Phase 3Active
- Sponsor
- Sichuan Academy of Chinese Medical Sciences
- Start
- Oct 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Dan'ge Fentong Capsules in diabetic polyneuropathy (DPN), sponsored by Sichuan Academy of Chinese Medical Sciences. Started Oct 2024; status: active.
02
Drugs
Dan'ge Fentong Capsules
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on CTR20243261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243261.